FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

Moderna Wins Approval for mRNA Flu Vaccine

FDA approves a Moderna BLA for mFLUSIVA (mRNA-1010), a new influenza vaccine for use in all adults 50 years and older.

latest-news-card-1
Human Drugs

FDA Signals Increased Scrutiny of Unapproved Animal-Derived Thyroid Drugs

FDA signals that increased regulatory oversight might be on the horizon for unapproved animal-derived thyroid medications, which are used by an estima...

Human Drugs

Surge In FDA Drug Warning Letters Shows Structural Problem: Consultant

Krieger Scientific founder Joseph Morwald says a surge in FDA drug Warning Letters is driven by an industry systemic problem that is being ignored rat...

Medical Devices

AdvaMed Strongly Backs MDUFA 6 Agreement

AdvaMed voices strong public support for the MDUFA 6 commitment reached with FDA.

Human Drugs

FDA Launches DSCSA Small Dispenser Assessment

FDA calls on small drug dispensers with no more than 25 employees to complete an assessment so the agency can evaluate the dispensers ability to condu...

latest-news-card-1
Human Drugs

Senators Press FDA for Details on Addressing Chemotherapy Shortages

Two senior U.S. senators seek answers from FDA about its plans to address ongoing shortages of several critical chemotherapy drugs.

latest-news-card-1
Human Drugs

FDA Outlines IND Pilot to Speed Early Clinical Trials, Counter Overseas Competition

FDA outlines its intention to overhaul the early-stage clinical development process through a planned Expedited IND Pilot, arguing that the changes ar...

Animal Drugs

Antimicrobial Animal Drug Finalized Safety Guidance

FDA issues a finalized guidance on evaluating the safety of antimicrobial animal drugs based on their role in human medicine.

Human Drugs

Quantitative Medicine Innovation Network RFI

FDA seeks information from a variety of regulatory partners that will help it establish and implement a Quantitative Medicine Innovation Network.

latest-news-card-1
Human Drugs

FDA, Tonix Align on Lyme Disease Prevention Phase 2 Study

FDA and Tonix Pharmaceuticals align on the protocol for an adaptive Phase 2 study of the companys TNX-4800 to prevent Lyme disease.